The severity of COVID-19 is attributed to the inflammatory status, presented as an increased inflammatory biomarker such as C-Reactive Protein (CRP), Interleukin 2 (IL-2), and Interleukin 6 (IL-6), which are predictors of mortality2. This evidence concerns the gene IL2 and COVID-19.